Hoffman Robert E. 4

4 · CytoDyn Inc. · Filed Mar 24, 2026

AI-generated summary of this filing

Updated Mar 24, 2026

CytoDyn (CYDY) CFO Robert E. Hoffman Receives 4.87M Share Award

What Happened

Robert E. Hoffman, Chief Financial Officer of CytoDyn Inc. (CYDY), was granted an award of 4,874,691 shares on March 20, 2026. The grant is reported as a derivative acquisition at $0.00 per share (transaction code A — Award/Grant) and therefore shows no immediate cash value on grant. The award was made under the Company’s 2012 Equity Incentive Plan.

Key Details

Transaction date: 2026-03-20; filing date: 2026-03-24 (appears to be 4 days after the transaction; potentially late under the Form 4 two-business-day rule).
Shares granted: 4,874,691; reported acquisition price: $0.00 (award).
Vesting: 1,218,672 shares vest on March 20, 2027; the remaining 3,656,019 shares vest in approximately equal monthly installments beginning April 2027 through March 2030 (~101,556 shares/month).
Source/authority: Approved by the Compensation Committee and issued from shares reserved under the 2012 Equity Incentive Plan (per filing footnotes).
Shares owned after the transaction: not disclosed in the provided filing details.

Context

This is a compensation award (not an open-market purchase or sale). Such grants are routine for executive pay and indicate future potential ownership only as shares vest. Because the award vests over several years, it does not represent immediate liquidity or a sale.

Form 4

Period: 2026-03-20

Chief Financial Officer

Transactions

Award
Non-qualified stock option (right to buy)
[F1][F2]
2026-03-20+4,874,691→ 4,874,691 total
Exercise: $0.28Exp: 2036-03-20→ Common Stock (4,874,691 underlying)

Footnotes (2)

[F1]This grant was approved by the Company's Compensation Committee on March 20, 2026, and represents the annual grant to the individual for fiscal year 2026 consistent with past practice in recent years. This award was made in compliance with, and uses shares that are specifically reserved for issuance to employees, directors, and certain outside consultants under, the Issuer's 2012 Equity Incentive Plan, as amended (the "2012 Plan").
[F2]1,218,672 shares will vest on March 20, 2027, and the balance will vest in approximately equal installments on the same day of each month of Continuous Service (as the term is defined in the 2012 Plan) beginning April 2027 through March 2030.

Signature

/s/ Tyler Blok, attorney-in-fact for Robert E. Hoffman|2026-03-24

1 file